Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction

The American Journal of Medicine
M G ShlipakM McClellan

Abstract

Angiotensin converting-enzyme (ACE) inhibitors decrease mortality after myocardial infarction among patients with depressed left ventricular function. Beta blockers may also improve survival in these patients. We compared the relative effects of these agents on the survival of elderly patients with a left ventricular ejection fraction less than 40% after myocardial infarction. The Cooperative Cardiovascular Project collected data on patients aged 65 years and older who were admitted with myocardial infarction from April 1994 to July 1995, including 20,902 with a measured left ventricular ejection fraction less than 40% before discharge. Using proportional hazard regression models that adjusted for patient characteristics and in-hospital treatments, we compared survival among patients discharged on ACE inhibitors, beta blockers, both medications, or neither medication. Among patients surviving hospitalization with reduced left ventricular function, 9,108 (44%) were discharged on ACE inhibitors, 2,613 (13%) on beta blockers, 3,309 (16%) on both medications, and 5,872 (28%) on neither medication. Patients treated with ACE inhibitors were more likely to have a prior diagnosis of heart failure and less likely to have undergone revas...Continue Reading

References

Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Mar 1, 1985·Progress in Cardiovascular Diseases·S YusufP Sleight
Jul 11, 1988·The American Journal of Cardiology·C D Furberg, S Yusuf
Apr 2, 1981·The New England Journal of Medicine·UNKNOWN Norwegian Multicenter Study Group
Mar 26, 1982·JAMA : the Journal of the American Medical Association
May 15, 1998·JAMA : the Journal of the American Medical Association·T A MarciniakS F Jencks
Aug 26, 1998·The New England Journal of Medicine·S S GottliebR A Vogel

❮ Previous
Next ❯

Citations

Nov 7, 2013·QJM : Monthly Journal of the Association of Physicians·D ZachariahP R Kalra
Aug 29, 2012·The American Journal of Medicine·Dharam J KumbhaniUNKNOWN Get With the Guidelines Steering Committee and Investigators
Apr 5, 2011·Cardiology Clinics·Robert J Mentz, Eldrin F Lewis
Jul 16, 2010·Heart Failure Clinics·Robert J Mentz, Eldrin F Lewis
Oct 22, 2008·The American Journal of Cardiology·Sang-Hee LeeUNKNOWN Korean Acute Myocardial Infarction Registry Investigators
Mar 29, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert J GoldbergFrederick A Spencer
Sep 4, 2007·British Journal of Clinical Pharmacology·Daniela DobreFlora M Haaijer-Ruskamp
Feb 28, 2006·Journal of Cardiac Failure· Heart Failure Society Of America
Aug 4, 2009·European Journal of Heart Failure·Alain Cohen-SolalUNKNOWN SENIORS Investigators
Jun 25, 2014·BioMed Research International·Liviu SegallAdrian Covic
Oct 19, 2004·Journal of the American College of Cardiology·Justin EzekowitzUNKNOWN APPROACH Investigators
Jan 31, 2007·The American Journal of Cardiology·Ali AhmedMichael G Shlipak
Jul 31, 2002·The Journal of Clinical Hypertension·L Michael Prisant
Sep 24, 2004·Pharmacoepidemiology and Drug Safety·Sherry WeitzenVincent Mor
May 10, 2011·Medicinski pregled·Vesna V Radović
Dec 17, 2010·World Journal of Cardiology·Farhan AslamJacob Joseph
May 22, 2018·Expert Review of Clinical Pharmacology·Syed Raza Shah, David E Winchester
Feb 26, 2015·Circulation·Jeffrey B WashamUNKNOWN American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology, Council on Cardiovascular
Oct 31, 2006·Phytotherapy Research : PTR·Monica Rosa LoizzoFrancesco Menichini
Jun 4, 2008·Current Opinion in Cardiology·Chiara Melloni, Kenneth W Mahaffey
Oct 26, 2005·Drugs & Aging·Wafik Farah AndrawesJoël Belmin
Jun 3, 2009·Current Heart Failure Reports·Henry KrumSuree Lekawanvijit
Aug 30, 2008·Circulation Journal : Official Journal of the Japanese Circulation Society·Sang-Hee LeeUNKNOWN Korean Acute Myocardial Infarction Registry Investigators
Aug 27, 2009·Journal of Cardiovascular Medicine·Nicola AcquaronePaolo Bellotti
Nov 3, 2006·The Journal of Bone and Joint Surgery. American Volume·Terry R Light
Jan 20, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kenichi MatsushitaHideaki Yoshino
Sep 3, 2003·Biological & Pharmaceutical Bulletin·Dae Gill KangHo Sub Lee
Oct 4, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Hui ZhouSteven J Jacobsen
May 25, 2002·Progress in Cardiovascular Diseases·Neuza LopesPascal J Goldschmidt

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.